Bridget Gordon is a highly accomplished research scientist at Assay Solutions, LLC, where she serves as a Surface Plasmon Resonance (SPR) and Bio-Layer Interferometry (BLI) Assay Development Consultant and Trainer. With over twenty years of experience in biological drug discovery R&D, Bridget has honed her...
Bridget Gordon is a highly accomplished research scientist at Assay Solutions, LLC, where she serves as a Surface Plasmon Resonance (SPR) and Bio-Layer Interferometry (BLI) Assay Development Consultant and Trainer. With over twenty years of experience in biological drug discovery R&D, Bridget has honed her expertise in developing innovative assays that are critical for advancing therapeutic candidates. Her role involves the intricate development of a wide range of SPR assays, encompassing interactions from small molecules to complex protein-protein and virus-protein engagements. This breadth of experience positions her as a key contributor to the field of proteomics and drug development.
In addition to her technical prowess, Bridget is a dedicated educator, having taught numerous week-long training courses focused on SPR theory, application, and assay development. Her ability to convey complex concepts in an accessible manner has empowered many researchers and scientists to enhance their skills in assay development, thereby accelerating the pace of innovation in the life sciences sector.
Bridget is also adept in the optimization of ELISA and cell-based assays, utilizing advanced equipment such as MSD and PE Envision plate readers and FACS. Her comprehensive skill set includes immunology, high-throughput screening, and laboratory automation, making her a versatile asset in any research environment. As a thought leader in technology transfer, Bridget continues to drive advancements in assay methodologies, ensuring that cutting-edge techniques are seamlessly integrated into the drug discovery pipeline. Her commitment to excellence and innovation in assay development not only enhances the capabilities of Assay Solutions but also contributes significantly to the broader biotechnology landscape.